Comparison of Patient-Controlled Analgesia With Different Background Infusion

Overview

In this study, the investigators investigated the efficacy, usefulness and analgesic consumption of three different patient-controlled analgesia(PCA) programmes:bolus dose alone without background infusion, bolus dose with low background infusion and bolus dose with high background infusion to evaluate postoperative analgesia for patients after laparoscopic colorectal surgery.

Full Title of Study: “Comparison of Intravenous Patient-Controlled Analgesia With Different Background Infusion After Colorectal Surgery”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: June 30, 2017

Detailed Description

There have been many studies using patient-controlled analgesia (PCA) and opioids for postoperative analgesia.Patient-controlled analgesia with opioids is now widely used after surgery for the treatment of acute postoperative pain. This technique provides effective pain treatment, adjusts the dose according to personal need and keeps plasma analgesic levels at a constant level,but the incidence of opioid-induced side-effects still be reported frequently.A proper PCA programme may increase efficiency of analgesic and decrease incidence of analgesic-induced side-effects. In this study, 90 patients who is undergoing elective laparoscopic colorectal surgery will be randomly allocated into three groups (no background infusion group(Group B0),low background infusion group(Group B1) and high background infusion group(Group B2)). Patients in all groups will be given a patient-controlled analgesia (PCA) pump in post anesthetic recovery unit (PACU) after surgery.The PCA programme of Group B0 is dezocine 0.6mg/kg, flubiprofen 3mg/kg, diluted into 120ml and administer at a background infusion of 0ml/h, and a bolus of 4ml, with a lock-out of 15min. The PCA protocol of Group B1 is dezocine 0.6mg/kg,flubiprofen 3mg/k diluted into 120ml and administer at a background infusion of 1ml/h, and a bolus of 2ml, with a lock-out of 15min.The PCA protocol of Group B2 is dezocine 0.6mg/kg,flubiprofen 3mg/k diluted into 120ml and administer at a background infusion of 2ml/h, and a bolus of 2ml, with a lock-out of 15min.

Interventions

  • Device: Patient-Controlled Analgesia(PCA)
    • Patients receive analgesic regimens using Patient-Controlled Analgesia(PCA) with different background infusion.

Arms, Groups and Cohorts

  • Experimental: No Background Infusion Group(Group B0)
    • Patients in Group B0 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 0ml/h.
  • Experimental: Low Background Infusion Group(Group B1)
    • Patients in Group B1 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 1ml/h.
  • Experimental: High Background Infusion Group(Group B2)
    • Patients in Group B2 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 2ml/h.

Clinical Trial Outcome Measures

Primary Measures

  • Dezocine consumption by patient-controlled analgesia
    • Time Frame: At 24 hours after surgery
    • The total consumption of dezocine during 24 hours after surgery are recorded.

Secondary Measures

  • The incidence rates of postoperative nausea and vomiting (PONV)
    • Time Frame: At 24 hours and 48 hours after surgery
    • Measure whether nausea and vomiting exist and the level of severity.
  • Change in ramsay sedation score
    • Time Frame: At 0, 2, 4, 8, 24, 48 and 72 hours after surgery
    • Measure sedation level by using ramsay sedation score.
  • Change in pain score
    • Time Frame: At 0, 2, 4, 8, 24, 48 and 72 hours after surgery
    • Pain scores at rest and movement are evaluated with a numeric rating scale (NRS)

Participating in This Clinical Trial

Inclusion Criteria

1. American Society of Anesthesiologists(ASA) Ⅰ-Ⅱ patient undergoing laparoscopic colorectal surgery 2. Written informed consent from the patient or the relatives of the participating patient. 3. BMI:18~30kg/m2 Exclusion Criteria:

1. Mental illness or cannot communicate.; 2. A second operation during the study; 3. Lung infection or sleep apnea syndrome; 4. Renal failure; 5. Alcohol or drug abuse; 6. Already taking gabapentin, pregabalin, benzodiazepin or antidepression drug; 7. Long-term use of analgesics,sedatives or non steroidal anti-inflammatory drugs history .

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Weifeng Tu
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Weifeng Tu, Chief physician – Guangzhou General Hospital of Guangzhou Military Command

References

Doyle E, Harper I, Morton NS. Patient-controlled analgesia with low dose background infusions after lower abdominal surgery in children. Br J Anaesth. 1993 Dec;71(6):818-22. doi: 10.1093/bja/71.6.818.

Yildiz K, Tercan E, Dogru K, Ozkan U, Boyaci A. Comparison of patient-controlled analgesia with and without a background infusion after appendicectomy in children. Paediatr Anaesth. 2003 Jun;13(5):427-31. doi: 10.1046/j.1460-9592.2003.01061.x.

White I, Ghinea R, Avital S, Chazan S, Dolkart O, Weinbroum AA. Morphine at "sub-analgesic" background infusion rate plus low-dose PCA bolus control pain better and is as safe as twice a bolus-only PCA regimen: a randomized, double blind study. Pharmacol Res. 2012 Aug;66(2):185-91. doi: 10.1016/j.phrs.2012.03.016. Epub 2012 Apr 6.

Hayes J, Dowling JJ, Peliowski A, Crawford MW, Johnston B. Patient-Controlled Analgesia Plus Background Opioid Infusion for Postoperative Pain in Children: A Systematic Review and Meta-Analysis of Randomized Trials. Anesth Analg. 2016 Oct;123(4):991-1003. doi: 10.1213/ANE.0000000000001244.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.